QA: Idexx Laboratories INC DE in us_medicinal_products/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000874716_2021_Idexx_Laboratories_INC_DE.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.37806637880283794, 'aggregate_val': 2437203000, 'exp_sum': 3918751000, 'exp_to_value': {'AssetsCurrent': 955655000, 'AssetsNoncurrent': 1481548000, 'PropertyPlantAndEquipmentNet': 587667000, 'Goodwill': 458380000, 'remainder_Assets': 435501000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.3601935373069781, 'aggregate_val': 1747211000, 'exp_sum': 2730843000, 'exp_to_value': {'LiabilitiesNoncurrent': 983632000, 'LiabilitiesCurrent': 772514000, 'remainder_Liabilities': 974697000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.3493161833765126, 'aggregate_val': 2294561000, 'exp_sum': 3526384000, 'exp_to_value': {'AssetsCurrent': 1062738000, 'AssetsNoncurrent': 1231823000, 'PropertyPlantAndEquipmentNet': 555167000, 'Goodwill': 295890000, 'remainder_Assets': 380766000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.39368666699990623, 'aggregate_val': 1661766000, 'exp_sum': 2740771000, 'exp_to_value': {'LiabilitiesNoncurrent': 1079005000, 'LiabilitiesCurrent': 594468000, 'remainder_Liabilities': 1067298000}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000874716, Idexx Laboratories INC DE

  xvar xval
0 LiabilitiesNoncurrent 1,079,005,000
1 LiabilitiesCurrent 594,468,000
2 remainder_Liabilities -11,707,000
3 AssetsCurrent 1,062,738,000
4 AssetsNoncurrent 1,231,823,000
5 PropertyPlantAndEquipmentNet 555,167,000
6 Goodwill 295,890,000
7 remainder_Assets -851,057,000
8 GeneralAndAdministrativeExpense 1,870,882,000
9 ResearchAndDevelopmentExpense 141,249,000
10 remainder_Expenses 112,979,000
11 remainder_Revenues 2,707,241,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -7,788,000
  yvar yval
0 Liabilities 1,661,766,000
1 Assets 2,294,561,000
2 Expenses 2,125,110,000
3 Revenues 2,707,241,000
4 StockholdersEquity 632,795,000
5 NetIncome 582,131,000
6 ComprehensiveNetIncome 578,237,000
7 BaseVar 4,398,233,000
8 EconomicCapitalRatiobeforeLimitedLiability 0.731
9 EconomicCapitalRatio 1.48

Edgar->Model Mapping

Feature Distribution

Change over Time